5-Oxo-4,5-dihydro-1H-[1,2,4]triazole-3-carboxylic acid

Catalog No. :
ACROXS571
CAS No. :
4538-16-3
Molecular Formula :
C3H3N3O3
Molecular Weight :
129.07

IUPAC Name:5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid

5-Oxo-4,5-dihydro-1H-[1,2,4]triazole-3-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$102.00Login to see priceIn stockInquiry
100mg95%$124.00Login to see priceIn stockInquiry
250mg95%$149.00Login to see priceIn stockIn stock
1g95%$232.00Login to see priceIn stockIn stock
5g95%$1126.00Login to see priceIn stockIn stock

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Oxo-4,5-dihydro-1H-[1,2,4]triazole-3-carboxylic acid
IUPAC Name5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid
MDL No.MFCD00526072
Molecular FormulaC3H3N3O3
Molecular Weight129.07
SMILESO=C(C(N1)=NNC1=O)O
InChI KeyKNSPHEMRHVERJM-UHFFFAOYSA-N
Synonym5-OXO-4,5-DIHYDRO-1H-[1,2,4]TRIAZOLE-3-CARBOXYLIC ACID;AKOS AU36-M362;ASINEX-REAG BAS 10142521;5-keto-1,2-dihydro-1,2,4-triazole-3-carboxylic acid;5-oxo-1,2-dihydro-1,2,4-triazole-3-carboxylic acid;1H-1,2,4-Triazole-3-carboxylic acid, 2,5-dihydro-5-oxo-
CAS No.4538-16-3
PubChem CID135413392

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACROXS571 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACROXS571 route product structure diagram
    ACROXS5714538-16-3 In Stock
Inquiry

2. ACROXS571 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRDOK390 route compound structure diagram
    ACRDOK39057281-13-7 In Stock
  2. Then
  3. ACROXS571 route product structure diagram
    ACROXS5714538-16-3 In Stock
Inquiry

Comments (0)